Robust affiliation between malnutrition, irritation, and atherosclerosis in power renal failure.
Background
Atheroscleroticcardiovascular illness and malnutrition are widely known as main causes of the elevated morbidity and mortality noticed in uremic sufferers. C-reactive protein (CRP), an acute-phase protein, is a predictor of cardiovascular mortality in nonrenal affected person populations. In power renal failure (CRF), the prevalence of an acute-phase response has been related to an elevated mortality.
METHODS
100 and 9 predialysis sufferers (age 52 +/- 1 years) with terminal CRF (glomerular filtration charge 7 +/- 1 ml/min) have been studied. Through the use of noninvasive B-mode ultrasonography, the cross-sectional carotid intima-media space was calculated, and the presence or absence of carotid plaques was decided.
Dietary standing was assessed by subjective world evaluation (SGA), dual-energy x-ray absorptiometry (DXA), serum albumin, serum creatinine, serum urea, and 24-hour urine urea excretion. The presence of an inflammatory response was assessed by CRP, fibrinogen (N = 46), and tumor necrosis factor-alpha (TNF-alpha; N = 87). Lipid parameters, together with Lp(a) and apo(a)-isoforms, in addition to markers of oxidative stress (autoantibodies in opposition to oxidized low-density lipoprotein and vitamin E), have been additionally decided.
RESULTS
In contrast with wholesome controls, CRF sufferers had an elevated imply carotid intima-media space (18.3 +/- 0.6 vs. 13.2 +/- 0.7 mm2, P < 0.0001) and a better prevalence of carotid plaques (72 vs. 32%, P = 0.001). The prevalence of malnutrition (SGA 2 to 4) was 44%, and 32% of all sufferers had an acute-phase response (CRP>> or = 10 mg/liter).
Malnourished sufferers had larger CRP ranges (23 +/- Three vs. 13 +/- 2 mg/liter, P < 0.01), elevated calculated intima-media space (20.2 +/- 0.eight vs. 16.9 +/- 0.7 mm2, P < 0.01) and a better prevalence of carotid plaques (90 vs. 60%, P < 0.0001) in contrast with well-nourished sufferers.
Throughout stepwise multivariate evaluation adjusting for age and gender, vitamin E (P < 0.05) and CRP (P < 0.05) remained related to an elevated intima-media space. The presence of carotid plaques was considerably related to age (P < 0.001), log oxidized low-density lipoprotein (oxLDL; P < 0.01), and small apo(a) isoform dimension (P < 0.05) in a multivariate logistic regression mannequin.
CONCLUSIONS
These outcomes point out that the quickly growing atherosclerosis in superior CRF seems to be attributable to a synergism of various mechanisms, similar to malnutrition, irritation, oxidative stress, and genetic parts. Aside from basic danger components, low vitamin E ranges and elevated CRP ranges are related to an elevated intima-media space, whereas small molecular weight apo(a) isoforms and elevated ranges of oxLDL are related to the presence of carotid plaques.
GPR61 antibody |
|||
| 20R-GR035 | Fitzgerald | 50 ug | EUR 709 |
|
Description: Rabbit polyclonal GPR61 antibody |
|||
GPR61 antibody |
|||
| 20R-GR069 | Fitzgerald | 50 ug | EUR 709 |
|
Description: Rabbit polyclonal GPR61 antibody |
|||
GPR61 antibody |
|||
| 20R-GR070 | Fitzgerald | 50 ug | EUR 709 |
|
Description: Rabbit polyclonal GPR61 antibody |
|||
GPR61 Antibody |
|||
| DF2755 | Affbiotech | 200ul | EUR 420 |
GPR61 Antibody |
|||
| DF2755-100ul | Affinity Biosciences | 100ul | EUR 168 |
|
Description: WB,ELISA(peptide) |
|||
GPR61 Antibody |
|||
| DF2755-200ul | Affinity Biosciences | 200ul | EUR 210 |
|
Description: WB,ELISA(peptide) |
|||
GPR61 Antibody |
|||
| DF2810 | Affbiotech | 200ul | EUR 420 |
GPR61 Antibody |
|||
| DF2810-100ul | Affinity Biosciences | 100ul | EUR 168 |
|
Description: WB,ELISA(peptide) |
|||
GPR61 Antibody |
|||
| DF2810-200ul | Affinity Biosciences | 200ul | EUR 210 |
|
Description: WB,ELISA(peptide) |
|||
GPR61 Antibody |
|||
| C43983-100ul | Assay Biotech | 100μl | EUR 217 |
|
Description: GPR61 Rabbit Polyclonal Antibody |
|||
GPR61 Antibody |
|||
| C43983-50ul | Assay Biotech | 50μl | EUR 143.5 |
|
Description: GPR61 Rabbit Polyclonal Antibody |
|||
GPR61 antibody |
|||
| MBS535608-005mg | MyBiosource | 0.05mg | EUR 1125 |
GPR61 antibody |
|||
| MBS535608-5x005mg | MyBiosource | 5x0.05mg | EUR 4905 |
GPR61 antibody |
|||
| MBS535619-005mg | MyBiosource | 0.05mg | EUR 1125 |
GPR61 antibody |
|||
| MBS535619-5x005mg | MyBiosource | 5x0.05mg | EUR 4905 |
GPR61 antibody |
|||
| MBS535674-005mg | MyBiosource | 0.05mg | EUR 1125 |
GPR61 antibody |
|||
| MBS535674-5x005mg | MyBiosource | 5x0.05mg | EUR 4905 |
GPR61 Antibody |
|||
| MBS9604269-01mL | MyBiosource | 0.1mL | EUR 260 |
GPR61 Antibody |
|||
| MBS9604269-02mL | MyBiosource | 0.2mL | EUR 305 |
GPR61 Antibody |
|||
| MBS9604269-5x02mL | MyBiosource | 5x0.2mL | EUR 1220 |
GPR61 Antibody |
|||
| MBS9604324-01mL | MyBiosource | 0.1mL | EUR 260 |
GPR61 Antibody |
|||
| MBS9604324-02mL | MyBiosource | 0.2mL | EUR 305 |
GPR61 Antibody |
|||
| MBS9604324-5x02mL | MyBiosource | 5x0.2mL | EUR 1220 |
GPR61 Antibody |
|||
| MBS9418327-005mL | MyBiosource | 0.05mL | EUR 245 |
GPR61 Antibody |
|||
| MBS9418327-01mL | MyBiosource | 0.1mL | EUR 305 |
GPR61 Antibody |
|||
| MBS9418327-5x01mL | MyBiosource | 5x0.1mL | EUR 1230 |
G Protein-Coupled Receptor GPR61 Rabbit anti-Human Polyclonal Antibody |
|||
| GWB-A590FB | GenWay Biotech | 0.05 mg | Ask for price |
G Protein-Coupled Receptor GPR61 Rabbit anti-Human Polyclonal Antibody |
|||
| GWB-229204 | GenWay Biotech | 0.05 mg | Ask for price |
G Protein-Coupled Receptor GPR61 Rabbit anti-Human Polyclonal Antibody |
|||
| GWB-1215F5 | GenWay Biotech | 0.05 mg | Ask for price |
GPR61 Polyclonal Antibody |
|||
| ABP58695-003ml | Abbkine | 0.03ml | EUR 189.6 |
|
Description: A polyclonal antibody for detection of GPR61 from Human, Mouse. This GPR61 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human GPR61 protein at amino acid sequence of 190-270 |
|||
GPR61 Polyclonal Antibody |
|||
| ABP58695-01ml | Abbkine | 0.1ml | EUR 346.8 |
|
Description: A polyclonal antibody for detection of GPR61 from Human, Mouse. This GPR61 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human GPR61 protein at amino acid sequence of 190-270 |
|||
GPR61 Polyclonal Antibody |
|||
| ABP58695-02ml | Abbkine | 0.2ml | EUR 496.8 |
|
Description: A polyclonal antibody for detection of GPR61 from Human, Mouse. This GPR61 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human GPR61 protein at amino acid sequence of 190-270 |
|||
GPR61 Polyclonal Antibody |
|||
| BT-AP15770-100ul | Jiaxing Korain Biotech Ltd (BT Labs) | 100ul | Ask for price |
|
Description: This gene belongs to the G-protein coupled receptor 1 family. G protein-coupled receptors contain 7 transmembrane domains and transduce extracellular signals through heterotrimeric G proteins. The protein encoded by this gene is most closely related to biogenic amine receptors. |
|||
GPR61 Polyclonal Antibody |
|||
| BT-AP15770-20ul | Jiaxing Korain Biotech Ltd (BT Labs) | 20ul | Ask for price |
|
Description: This gene belongs to the G-protein coupled receptor 1 family. G protein-coupled receptors contain 7 transmembrane domains and transduce extracellular signals through heterotrimeric G proteins. The protein encoded by this gene is most closely related to biogenic amine receptors. |
|||
GPR61 Polyclonal Antibody |
|||
| BT-AP15770-50ul | Jiaxing Korain Biotech Ltd (BT Labs) | 50ul | Ask for price |
|
Description: This gene belongs to the G-protein coupled receptor 1 family. G protein-coupled receptors contain 7 transmembrane domains and transduce extracellular signals through heterotrimeric G proteins. The protein encoded by this gene is most closely related to biogenic amine receptors. |
|||
GPR61 Conjugated Antibody |
|||
| C44933 | SAB | 100ul | EUR 476.4 |
GPR61 Polyclonal Antibody |
|||
| E11-202531 | EnoGene | 100ug/100ul | EUR 225 |
|
Description: Available in various conjugation types. |
|||
GPR61 Polyclonal Antibody |
|||
| JOT-AP15770-100ul | Jotbody | 100ul | EUR 220 |
GPR61 Polyclonal Antibody |
|||
| JOT-AP15770-50ul | Jotbody | 50ul | EUR 144 |
GPR61 Polyclonal Antibody |
|||
| E44H10138 | EnoGene | 100ul | EUR 255 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
GPR61 Polyclonal Antibody |
|||
| MBS8531891-01mg | MyBiosource | 0.1mg | EUR 305 |
GPR61 Polyclonal Antibody |
|||
| MBS8531891-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 465 |
GPR61 Polyclonal Antibody |
|||
| MBS8531891-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 465 |
GPR61 Polyclonal Antibody |
|||
| MBS8531891-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 465 |
GPR61 Polyclonal Antibody |
|||
| MBS8531891-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 465 |
GPR61 Conjugated Antibody |
|||
| MBS9452885-01mLAF350 | MyBiosource | 0.1mL(AF350) | EUR 480 |
GPR61 Conjugated Antibody |
|||
| MBS9452885-01mLAF405 | MyBiosource | 0.1mL(AF405) | EUR 480 |
GPR61 Conjugated Antibody |
|||
| MBS9452885-01mLAF488 | MyBiosource | 0.1mL(AF488) | EUR 480 |
GPR61 Conjugated Antibody |
|||
| MBS9452885-01mLAF555 | MyBiosource | 0.1mL(AF555) | EUR 480 |
GPR61 Conjugated Antibody |
|||
| MBS9452885-01mLBiotin | MyBiosource | 0.1mL(Biotin) | EUR 480 |
GPR61 Polyclonal Antibody |
|||
| UB-GEN-7232 | UpingBio | 100 ul | EUR 200 |
GPR61 Rabbit Polyclonal Antibody |
|||
| ES11477-100ul | ELK Biotech | 100ul | EUR 124 |
|
Description: WB, ELISA |
|||
GPR61 Rabbit Polyclonal Antibody |
|||
| ES11477-50ul | ELK Biotech | 50ul | EUR 74 |
|
Description: WB, ELISA |
|||
Human GPR61 Protein Lysate |
|||
| MBS8412523-002mg | MyBiosource | 0.02mg | EUR 365 |
Human GPR61 Protein Lysate |
|||
| MBS8412523-5x002mg | MyBiosource | 5x0.02mg | EUR 1410 |
GPR61 (untagged)-Human G protein-coupled receptor 61 (GPR61) |
|||
| SC106692 | Origene Technologies GmbH | 10 µg | Ask for price |
GPR61 (untagged)-Human G protein-coupled receptor 61 (GPR61) |
|||
| SC317735 | Origene Technologies GmbH | 10 µg | Ask for price |
GPR61 Antibody - N-terminal region |
|||
| MBS3223892-01mL | MyBiosource | 0.1mL | EUR 455 |
GPR61 Antibody - N-terminal region |
|||
| MBS3223892-5x01mL | MyBiosource | 5x0.1mL | EUR 1995 |
Polyclonal GPR61 Antibody (C-Terminus) |
|||
| APR16588G | Leading Biology | 0.05mg | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR61 (C-Terminus). This antibody is tested and proven to work in the following applications: |
|||
Polyclonal GPR61 Antibody (C-Terminus) |
|||
| APR16589G | Leading Biology | 0.05mg | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR61 (C-Terminus). This antibody is tested and proven to work in the following applications: |
|||
Polyclonal GPR61 Antibody (N-Terminus) |
|||
| APR16592G | Leading Biology | 0.05mg | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR61 (N-Terminus). This antibody is tested and proven to work in the following applications: |
|||
GPR61 Recombinant Protein (Rat) |
|||
| RP203447 | ABM | 100 ug | Ask for price |
Probable G-Protein Coupled Receptor 61 (GPR61) Antibody |
|||
| 20-abx147479 | Abbexa |
|
|
Probable G-Protein Coupled Receptor 61 (GPR61) Antibody |
|||
| abx147479-1096tests | Abbexa | 10 × 96 tests | Ask for price |
Probable G-Protein Coupled Receptor 61 (GPR61) Antibody |
|||
| abx147479-596tests | Abbexa | 5 × 96 tests | EUR 387.5 |
Probable G-Protein Coupled Receptor 61 (GPR61) Antibody |
|||
| abx147479-96tests | Abbexa | 96 tests | EUR 300 |
Probable G-Protein Coupled Receptor 61 (GPR61) Antibody |
|||
| abx147480-100ug | Abbexa | 100 ug | EUR 526.8 |
GPR61 Recombinant Protein (Human) |
|||
| RP013882 | ABM | 100 ug | Ask for price |
GPR61 Recombinant Protein (Mouse) |
|||
| RP139673 | ABM | 100 ug | Ask for price |
Polyclonal GPR61 Antibody (Cytoplasmic Domain) |
|||
| APR16590G | Leading Biology | 0.05mg | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR61 (Cytoplasmic Domain). This antibody is tested and proven to work in the following applications: |
|||
Polyclonal GPR61 Antibody (Extracellular Domain) |
|||
| APR16591G | Leading Biology | 0.05mg | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR61 (Extracellular Domain). This antibody is tested and proven to work in the following applications: |
|||
GPR61 (GFP-tagged) - Human G protein-coupled receptor 61 (GPR61) |
|||
| RG209672 | Origene Technologies GmbH | 10 µg | Ask for price |
Gpr61 (untagged) - Mouse G protein-coupled receptor 61 (Gpr61), (10ug) |
|||
| MC216046 | Origene Technologies GmbH | 10 µg | Ask for price |
Human GPR61 Protein Lysate 20ug |
|||
| IHUGPR61PLLY20UG | Innovative research | each | EUR 213 |
|
Description: Human GPR61 Protein Lysate 20ug |
|||
Gpr61 (GFP-tagged) - Mouse G protein-coupled receptor 61 (Gpr61), (10ug) |
|||
| MG216498 | Origene Technologies GmbH | 10 µg | Ask for price |
Gpr61 (Myc-DDK-tagged) - Mouse G protein-coupled receptor 61 (Gpr61) |
|||
| MR216498 | Origene Technologies GmbH | 10 µg | Ask for price |
GPR61 (Myc-DDK-tagged)-Human G protein-coupled receptor 61 (GPR61) |
|||
| RC209672 | Origene Technologies GmbH | 10 µg | Ask for price |
GPR61 Rabbit Polyclonal (N-Terminus) Antibody |
|||
| TA316841 | Origene Technologies GmbH | 50 µg | Ask for price |
GPR61 Rabbit Polyclonal (C-Terminus) Antibody |
|||
| TA316842 | Origene Technologies GmbH | 50 µg | Ask for price |
GPR61 Rabbit Polyclonal (C-Terminus) Antibody |
|||
| TA316843 | Origene Technologies GmbH | 50 µg | Ask for price |
OCOA07698-20UG - GPR61 Protein Lysate |
|||
| OCOA07698-20UG | Aviva Systems Biology | 20ug | EUR 169 |
Anti- GPR30 protein Antibody |
|||
| GWB-A0122E | GenWay Biotech | 0.05 ml | Ask for price |
Malnutrition-inflammation complicated syndrome in dialysis sufferers: causes and penalties.
Atherosclerotic heart problems and malnutrition are widely known as main causes of the elevated morbidity and mortality noticed in uremic sufferers. C-reactive protein (CRP), an acute-phase protein, is a predictor of cardiovascular mortality in nonrenal affected person populations. In power renal failure (CRF), the prevalence of an acute-phase response has been related to an elevated mortality.
METHODS
100 and 9 predialysis sufferers (age 52 +/- 1 years) with terminal CRF (glomerular filtration charge 7 +/- 1 ml/min) have been studied. Through the use of noninvasive B-mode ultrasonography, the cross-sectional carotid intima-media space was calculated, and the presence or absence of carotid plaques was decided.
Dietary standing was assessed by subjective world evaluation (SGA), dual-energy x-ray absorptiometry (DXA), serum albumin, serum creatinine, serum urea, and 24-hour urine urea excretion.
The presence of an inflammatory response was assessed by CRP, fibrinogen (N = 46), and tumor necrosis factor-alpha (TNF-alpha; N = 87). Lipid parameters, together with Lp(a) and apo(a)-isoforms, in addition to markers of oxidative stress (autoantibodies in opposition to oxidized low-density lipoprotein and vitamin E), have been additionally decided.
RESULTS
In contrast with wholesome controls, CRF sufferers had an elevated imply carotid intima-media space (18.3 +/- 0.6 vs. 13.2 +/- 0.7 mm2, P < 0.0001) and a better prevalence of carotid plaques (72 vs. 32%, P = 0.001). The prevalence of malnutrition (SGA 2 to 4) was 44%, and 32% of all sufferers had an acute-phase response (CRP>> or = 10 mg/liter).
Malnourished sufferers had larger CRP ranges (23 +/- Three vs. 13 +/- 2 mg/liter, P < 0.01), elevated calculated intima-media space (20.2 +/- 0.eight vs. 16.9 +/- 0.7 mm2, P < 0.01) and a better prevalence of carotid plaques (90 vs. 60%, P < 0.0001) in contrast with well-nourished sufferers.
Throughout stepwise multivariate evaluation adjusting for age and gender, vitamin E (P < 0.05) and CRP (P < 0.05) remained related to an elevated intima-media space. The presence of carotid plaques was considerably related to age (P < 0.001), log oxidized low-density lipoprotein (oxLDL; P < 0.01), and small apo(a) isoform dimension (P < 0.05) in a multivariate logistic regression mannequin.
CONCLUSIONS
These outcomes point out that the quickly growing atherosclerosis in superior CRF seems to be attributable to a synergism of various mechanisms, similar to malnutrition, irritation, oxidative stress, and genetic parts. Aside from basic danger components, low vitamin E ranges and elevated CRP ranges are related to an elevated intima-media space, whereas small molecular weight apo(a) isoforms and elevated ranges of oxLDL are related to the presence of carotid plaques.
- Protein-energy malnutrition (PEM) and irritation are widespread and often concurrent in upkeep dialysis sufferers. Many components that seem to result in these 2 situations overlap, as do evaluation instruments and such standards for detecting them as hypoalbuminemia.
- Each these situations are associated to poor dialysis end result. Low urge for food and a hypercatabolic state are amongst widespread options. PEM in dialysis sufferers has been advised to be secondary to irritation; nonetheless, the proof isn’t conclusive, and an equicausal standing and even reverse causal route is feasible.
- Therefore, malnutrition-inflammation complicated syndrome (MICS) is an applicable time period. Attainable causes of MICS embody comorbid diseases, oxidative and carbonyl stress, nutrient loss by means of dialysis, anorexia and low nutrient consumption, uremic toxins, decreased clearance of inflammatory cytokines, quantity overload, and dialysis-related components.
- MICS is believed to be the primary reason behind erythropoietin hyporesponsiveness, excessive charge of cardiovascular atherosclerotic illness, decreased high quality of life, and elevated mortality and hospitalization in dialysis sufferers.
- As a result of MICS results in a low physique mass index, hypocholesterolemia, hypocreatininemia, and hypohomocysteinemia, a “reverse epidemiology” of cardiovascular dangers can happen in dialysis sufferers.
- Due to this fact, weight problems, hypercholesterolemia, and elevated blood ranges of creatinine and homocysteine look like protecting and paradoxically related to a greater end result.
- There isn’t a consensus about tips on how to decide the diploma of severity of MICS or tips on how to handle it. A number of diagnostic instruments and therapy modalities are mentioned. Profitable administration of MICS might ameliorate the cardiovascular epidemic and poor end result in dialysis sufferers.
- Scientific trials specializing in MICS and its doable causes and penalties are urgently required to enhance poor medical end result in dialysis sufferers.
EBV EBNA1 [GST] |
|||
| DAG1850 | Creative Diagnostics | 500 ug | EUR 2089.24 |
|
Description: Recombinant |
|||
EBV EBNA1 Mosaic |
|||
| ebv-271 | ProSpec Tany | 100µg | EUR 165 |
|
Description: Recombinant Epstein-Barr Virus (HHV-4) EBNA1 Mosaic |
|||
EBV EBNA1 antibody |
|||
| 20-EG46 | Fitzgerald | 1 mg | EUR 90 |
|
Description: Goat polyclonal EBV EBNA1 antibody |
|||
EBV EBNA1 antibody |
|||
| MBS534723-1mg | MyBiosource | 1mg | EUR 240 |
Recombinant EBV EBNA1 Protein, His, E.coli-1mg |
|||
| QP11731-1mg | EnQuireBio | 1mg | EUR 1873.2 |
Recombinant EBV EBNA1 Protein, His, E.coli-100ug |
|||
| QP11731-100ug | EnQuireBio | 100ug | EUR 381.6 |
Recombinant EBV EBNA1 Protein, His, E.coli-500ug |
|||
| QP11731-500ug | EnQuireBio | 500ug | EUR 1034.4 |
Recombinant EBV EBNA1 Mosaic Protein, His, E.coli-1mg |
|||
| QP11732-1mg | EnQuireBio | 1mg | EUR 1273.2 |
Recombinant EBV EBNA1 Mosaic Protein, His, E.coli-100ug |
|||
| QP11732-100ug | EnQuireBio | 100ug | EUR 261.6 |
Recombinant EBV EBNA1 Mosaic Protein, His, E.coli-500ug |
|||
| QP11732-500ug | EnQuireBio | 500ug | EUR 795.6 |
Recombinant EBV EBNA1 Mosaic Protein (aa 1-90 & 408-498) [GST] |
|||
| VAng-Lsx0111-100g | Creative Biolabs | 100 µg | EUR 759.6 |
|
Description: EBV EBNA1 Mosaic protein [GST], recombinant protein from E. coli. |
|||
Recombinant EBV EBNA1 Mosaic Protein (aa 1-90 & 408-498) [GST] |
|||
| VAng-Lsx0111-500g | Creative Biolabs | 500 µg | EUR 2419.2 |
|
Description: EBV EBNA1 Mosaic protein [GST], recombinant protein from E. coli. |
|||
Recombinant EBV EBNA1 Mosaic Protein (aa 1-90 & 408-498) [His] |
|||
| VAng-2528Lsx-100g | Creative Biolabs | 100 µg | EUR 555.6 |
|
Description: EBV EBNA1 Mosaic protein, His tag at C-terminus, recombinant protein from E. coli. |
|||
Recombinant EBV EBNA1 Mosaic Protein (aa 1-90 & 408-498) [His] |
|||
| VAng-2528Lsx-1mg | Creative Biolabs | 1 mg | EUR 3360 |
|
Description: EBV EBNA1 Mosaic protein, His tag at C-terminus, recombinant protein from E. coli. |
|||
Recombinant EBV EBNA1 Mosaic Protein (aa 1-90 & 408-498) [His] |
|||
| VAng-2528Lsx-500g | Creative Biolabs | 500 µg | EUR 2040 |
|
Description: EBV EBNA1 Mosaic protein, His tag at C-terminus, recombinant protein from E. coli. |
|||
Recombinant EBV EBNA1 Antigen, His-tagged |
|||
| VAC-0197 | Creative BioMart | 0.5ml | EUR 1598.4 |
|
Description: Protein |
|||
EBV Nuclear Antigen EBNA1. p72 (stabilized) |
|||
| BA1362R01 | Serion Immundiagnostica GmbH | 29 mg | EUR 715 |
Epstein Barr Virus, EBNA1, Recombinant (EBV) |
|||
| MBS637565-01mg | MyBiosource | 0.1mg | EUR 845 |
Epstein Barr Virus, EBNA1, Recombinant (EBV) |
|||
| MBS637565-5x01mg | MyBiosource | 5x0.1mg | EUR 3660 |
Recombinant EBV EBNA1 Mosaic Antigen, His-tagged |
|||
| VAC-0198 | Creative BioMart | 0.5ml | EUR 1598.4 |
|
Description: Protein |
|||
EBV EBNA protein |
|||
| 30-AE46 | Fitzgerald | 200 ug | EUR 667 |
|
Description: Purified recombinant EBV EBNA protein |
|||
EBV EBNA protein |
|||
| MBS538336-INQUIRE | MyBiosource | INQUIRE | Ask for price |
EBNA1 protein |
|||
| 30-1925 | Fitzgerald | 500 ug | EUR 495 |
|
Description: Purified Recombinant EBNA1 protein |
|||
RECOMBINANT ANTIGEN EBNA1 from Epstein-Barr Virus (EBV) |
|||
| MBS505053-1mg | MyBiosource | 1mg | EUR 1080 |
RECOMBINANT ANTIGEN EBNA1 from Epstein-Barr Virus (EBV) |
|||
| MBS505053-5x1mg | MyBiosource | 5x1mg | EUR 4575 |
Epstein Barr Virus, Nuclear Antigen, EBNA1, Recombinant (EBV) |
|||
| MBS636498-01mg | MyBiosource | 0.1mg | EUR 540 |
Epstein Barr Virus, Nuclear Antigen, EBNA1, Recombinant (EBV) |
|||
| MBS636498-5x01mg | MyBiosource | 5x0.1mg | EUR 2275 |
EBNA1 protein (His tag) |
|||
| 80-1340 | Fitzgerald | 100 ug | EUR 233 |
|
Description: Purified recombinant EBNA1 protein (His tag) |
|||
human anti-EBV NA1(EBNA1) IgA(4E3) |
|||
| E4A11A68-4E3-A | EnoGene | 100ug | EUR 995 |
human anti-EBV NA1(EBNA1) IgG(4E3) |
|||
| E4A11A68-4E3-G | EnoGene | 100ug | EUR 995 |
human anti-EBV NA1(EBNA1) IgM(4E3) |
|||
| E4A11A68-4E3-M | EnoGene | 100ug | EUR 995 |
human anti-EBV NA1(EBNA1) IgA(4K9) |
|||
| E4A11A68-4K9-A | EnoGene | 100ug | EUR 995 |
human anti-EBV NA1(EBNA1) IgG(4K9) |
|||
| E4A11A68-4K9-G | EnoGene | 100ug | EUR 995 |
human anti-EBV NA1(EBNA1) IgM(4K9) |
|||
| E4A11A68-4K9-M | EnoGene | 100ug | EUR 995 |
Recombinant EBNA1 Protein [GST] |
|||
| VAng-Lsx0122-100g | Creative Biolabs | 100 µg | EUR 818.4 |
|
Description: EBNA1 (EBV) (P03211) partial recombinant protein with GST tag expressed in E. coli. |
|||
Epstein Barr Virus, Nuclear Antigen, Recombinant EBNA1, 27kD CT (EBV) |
|||
| MBS636094-01mg | MyBiosource | 0.1mg | EUR 755 |
Epstein Barr Virus, Nuclear Antigen, Recombinant EBNA1, 27kD CT (EBV) |
|||
| MBS636094-5x01mg | MyBiosource | 5x0.1mg | EUR 3170 |
Purified Recombinant EBNA1 protein |
|||
| MBS5308620-05mg | MyBiosource | 0.5mg | EUR 795 |
Purified Recombinant EBNA1 protein |
|||
| MBS5308620-5x05mg | MyBiosource | 5x0.5mg | EUR 3430 |
EBNA1 Binding Protein 2 Protein |
|||
| abx260778-10g | Abbexa | 10 µg | EUR 325 |
EBNA1 Binding Protein 2 Protein |
|||
| 20-abx260778 | Abbexa |
|
|
EBNA1 Binding Protein 2 Protein |
|||
| abx260778-2g | Abbexa | 2 µg | EUR 225 |
Epstein Barr Virus, Nuclear Antigen, EBNA1, Mosaic, Recombinant (aa1-90, 408-498) (EBV) |
|||
| MBS638308-01mg | MyBiosource | 0.1mg | EUR 490 |
Epstein Barr Virus, Nuclear Antigen, EBNA1, Mosaic, Recombinant (aa1-90, 408-498) (EBV) |
|||
| MBS638308-05mg | MyBiosource | 0.5mg | EUR 1065 |
Epstein Barr Virus, Nuclear Antigen, EBNA1, Mosaic, Recombinant (aa1-90, 408-498) (EBV) |
|||
| MBS638308-5x05mg | MyBiosource | 5x0.5mg | EUR 4635 |
Anti-EBV/HHV-4 EBNA1/BKRF1 Antibody (3D4) |
|||
| MBS1569155-01mg | MyBiosource | 0.1mg | EUR 405 |
Anti-EBV/HHV-4 EBNA1/BKRF1 Antibody (3D4) |
|||
| MBS1569155-5x01mg | MyBiosource | 5x0.1mg | EUR 1520 |
Anti-EBV/HHV-4 EBNA1/BKRF1 Antibody (16D2) |
|||
| MBS1569156-01mg | MyBiosource | 0.1mg | EUR 405 |
Anti-EBV/HHV-4 EBNA1/BKRF1 Antibody (16D2) |
|||
| MBS1569156-5x01mg | MyBiosource | 5x0.1mg | EUR 1520 |
EBNA1 Binding Protein 2 (EBNA1BP2) Antibody |
|||
| abx026949-400l | Abbexa | 400 µl | EUR 518.75 |
EBNA1 Binding Protein 2 (EBNA1BP2) Antibody |
|||
| abx026949-400ul | Abbexa | 400 ul | EUR 627.6 |
EBNA1 Binding Protein 2 (EBNA1BP2) Antibody |
|||
| abx026949-80l | Abbexa | 80 µl | EUR 281.25 |
EBNA1 Binding Protein 2 (EBNA1BP2) Antibody |
|||
| abx123650-100l | Abbexa | 100 µl | EUR 175 |
EBNA1 Binding Protein 2 (EBNA1BP2) Antibody |
|||
| 20-abx123650 | Abbexa |
|
|
EBNA1 Binding Protein 2 (EBNA1BP2) Antibody |
|||
| abx123650-1ml | Abbexa | 1 ml | EUR 400 |
EBNA1 Binding Protein 2 (EBNA1BP2) Antibody |
|||
| abx123650-200l | Abbexa | 200 µl | EUR 275 |
Recombinant (E.Coli, GST tag) Epstein-Barr Virus (EBV/HHV-4) Mosaic EBNA1 |
|||
| RP-347 | Alpha Diagnostics | 100 ug | EUR 343.2 |
EBV Early Antigens (EBNA1, EBV nuclear antigen 1, Epstein Barr nuclear antigen 1, Human Herpesvirus 4 (HHV4)) (AP) |
|||
| MBS6123099-01mL | MyBiosource | 0.1(mL | EUR 935 |
EBV Early Antigens (EBNA1, EBV nuclear antigen 1, Epstein Barr nuclear antigen 1, Human Herpesvirus 4 (HHV4)) (AP) |
|||
| MBS6123099-5x01mL | MyBiosource | 5x0.1mL | EUR 4050 |
EBV Early Antigens (EBNA1, EBV nuclear antigen 1, Epstein Barr nuclear antigen 1, Human Herpesvirus 4 (HHV4)) (PE) |
|||
| MBS6123103-01mL | MyBiosource | 0.1(mL | EUR 935 |
EBV Early Antigens (EBNA1, EBV nuclear antigen 1, Epstein Barr nuclear antigen 1, Human Herpesvirus 4 (HHV4)) (PE) |
|||
| MBS6123103-5x01mL | MyBiosource | 5x0.1mL | EUR 4050 |
EBV Early Antigens (EBNA1, EBV nuclear antigen 1, Epstein Barr nuclear antigen 1, Human Herpesvirus 4 (HHV4)) (APC) |
|||
| MBS6123100-01mL | MyBiosource | 0.1(mL | EUR 935 |
EBV Early Antigens (EBNA1, EBV nuclear antigen 1, Epstein Barr nuclear antigen 1, Human Herpesvirus 4 (HHV4)) (APC) |
|||
| MBS6123100-5x01mL | MyBiosource | 5x0.1mL | EUR 4050 |
EBV Early Antigens (EBNA1, EBV nuclear antigen 1, Epstein Barr nuclear antigen 1, Human Herpesvirus 4 (HHV4)) (Biotin) |
|||
| MBS6123101-01mL | MyBiosource | 0.1(mL | EUR 935 |
EBV Early Antigens (EBNA1, EBV nuclear antigen 1, Epstein Barr nuclear antigen 1, Human Herpesvirus 4 (HHV4)) (Biotin) |
|||
| MBS6123101-5x01mL | MyBiosource | 5x0.1mL | EUR 4050 |
EBV Early Antigens (EBNA1, EBV nuclear antigen 1, Epstein Barr nuclear antigen 1, Human Herpesvirus 4 (HHV4)) (FITC) |
|||
| MBS6123102-01mL | MyBiosource | 0.1(mL | EUR 935 |
EBV Early Antigens (EBNA1, EBV nuclear antigen 1, Epstein Barr nuclear antigen 1, Human Herpesvirus 4 (HHV4)) (FITC) |
|||
| MBS6123102-5x01mL | MyBiosource | 5x0.1mL | EUR 4050 |
Purified recombinant EBNA1 protein (His tag) |
|||
| MBS5308460-07mg | MyBiosource | 0.7mg | EUR 1185 |
Purified recombinant EBNA1 protein (His tag) |
|||
| MBS5308460-5x07mg | MyBiosource | 5x0.7mg | EUR 5120 |
Recombinant EBNA1 Protein [His] (1.185 mg/mL) |
|||
| VAng-0610Lsx-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Epstein-Barr Virus (EBV) Nuclear Antigen-1 (EBNA-1), recombinant protein from E. coli. MW 63 kDa, 1.185 mg/mL. |
|||
Recombinant EBNA1 Protein [His] (1.25 mg/mL) |
|||
| VAng-0611Lsx-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Epstein-Barr Virus (EBV) Nuclear Antigen-1 (EBNA-1), recombinant protein from E. coli. MW 63 kDa, 1.25 mg/mL. |
|||
Epstein-Barr Virus (HHV-4) EBNA1 Protein |
|||
| 20-abx260340 | Abbexa |
|
|
EBNA1 binding protein 2 (EBNA1BP2) (NM_006824) Human Recombinant Protein |
|||
| E45H32372E1 | EnoGene | 50 ug | EUR 552.5 |
Human EBNA1 Binding Protein 2 (EBNA1BP2) ELISA Kit |
|||
| abx384822-96tests | Abbexa | 96 tests | EUR 687.5 |
Mouse EBNA1 Binding Protein 2 (EBNA1BP2) ELISA Kit |
|||
| abx389130-96tests | Abbexa | 96 tests | EUR 687.5 |
Epstein Barr Virus, Nuclear Antigen (Epstein-Barr Nuclear Antigen 1, EBV Nuclear Antigen 1, EBNA1, EBNA-1, EBV, BKRF1, Human Herpes virus 4, HHV4) |
|||
| MBS609692-01mg | MyBiosource | 0.1mg | EUR 580 |
Epstein Barr Virus, Nuclear Antigen (Epstein-Barr Nuclear Antigen 1, EBV Nuclear Antigen 1, EBNA1, EBNA-1, EBV, BKRF1, Human Herpes virus 4, HHV4) |
|||
| MBS609692-5x01mg | MyBiosource | 5x0.1mg | EUR 2470 |